Recent Updates
Recently added Catalysts
GREAT POINT PARTNERS LLC
Track GREAT POINT PARTNERS LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Aug 3, 2026
Showing 6 Stocks Out Of 42. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 CGEM | CULLINAN THERAPEUTICS INC | 300.00 K | 4.26 M | 1 | |
 LBRX | LB PHARMACEUTICALS INC | 300.00 K | 7.40 M | 1.7 | |
 CMPX | COMPASS THERAPEUTICS INC | 1.35 M | 7.14 M | 1.6 | |
 SCYX | SCYNEXIS INC | 7.55 M | 6.93 M | 1.6 | |
 PALI | PALISADE BIO INC | 3.41 M | 5.96 M | 1.4 | |
 CNTX | CONTEXT THERAPEUTICS INC | 2.24 M | 5.86 M | 1.3 |
Market Value
$ 435.10 M
Holdings
42
Period
Q1 2026
Holdings in Top 20
77.2 %
QoQ Changes
41.08 %